Erminia Ridolo Selected Research

Erminia Ridolo Research Topics

Disease

30	Hypersensitivity (Allergy) 05/2022 - 08/2011
27	Asthma (Bronchial Asthma) 05/2022 - 12/2009
12	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2013
9	Allergic Rhinitis 03/2020 - 01/2014
7	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2014
7	Rhinitis 01/2017 - 05/2010
5	Urticaria (Hives) 01/2021 - 01/2014
4	Mastocytosis 01/2022 - 12/2013
4	Chronic Urticaria 01/2021 - 01/2014
4	Bites and Stings (Sting) 01/2019 - 11/2015
4	Inflammation (Inflammations) 01/2018 - 05/2010
3	Atopic Dermatitis (Atopic Eczema) 05/2022 - 01/2015
3	Eosinophilic Esophagitis 01/2019 - 01/2011
3	Dyspnea (Shortness of Breath) 01/2016 - 01/2015
2	Rhinosinusitis 05/2022 - 01/2019
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021 - 12/2014
2	Food Hypersensitivity (Food Allergy) 01/2019 - 01/2015
2	Pneumonia (Pneumonitis) 01/2018 - 11/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 12/2013
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016 - 01/2015
1	Nasal Polyps (Nasal Polyp) 05/2022
1	Infections 01/2021
1	Allergic Bronchopulmonary Aspergillosis 01/2019
1	Esophagitis 01/2019
1	Keratoconjunctivitis 01/2019
1	Venom Hypersensitivity 01/2019
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2019
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2019
1	Photophobia (Light Sensitivity) 01/2019
1	Skin Diseases (Skin Disease) 01/2018
1	Drug Hypersensitivity (Drug Allergy) 01/2018
1	Confusion (Bewilderment) 02/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2017
1	Insect Bites and Stings (Insect Bite) 01/2017
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2016
1	Cough 01/2015

Drug/Important Bio-Agent (IBA)

22	AllergensIBA 01/2022 - 12/2009
12	Immunoglobulin E (IgE)IBA 12/2021 - 01/2014
8	Bronchodilator Agents (Bronchodilators)IBA 01/2020 - 01/2013
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
6	Omalizumab (Xolair)FDA Link 01/2021 - 01/2014
6	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 12/2014
5	Arthropod VenomsIBA 01/2022 - 11/2015
5	Muscarinic AntagonistsIBA 01/2019 - 01/2014
4	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2019 - 01/2014
4	indacaterolIBA 01/2019 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2018
3	VenomsIBA 01/2022 - 01/2017
2	dupilumabIBA 05/2022 - 10/2020
2	Tryptases (Tryptase)IBA 01/2022 - 12/2013
2	mepolizumabIBA 10/2020 - 01/2019
2	CytokinesIBA 10/2020 - 01/2019
2	Biological ProductsIBA 10/2020 - 01/2019
2	bilastineIBA 01/2020 - 01/2015
2	AntibodiesIBA 01/2017 - 11/2015
2	TabletsIBA 01/2017 - 01/2015
2	Histamine (Histamine Dihydrochloride)FDA Link 10/2016 - 06/2014
2	Formoterol Fumarate (Oxis)FDA Link 01/2016 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015 - 01/2014
2	Histamine Antagonists (Antihistamines)IBA 01/2015 - 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	benralizumabIBA 10/2020
1	anti-IgE antibodiesIBA 10/2020
1	reslizumabIBA 10/2020
1	Thymic Stromal LymphopoietinIBA 10/2020
1	Prostaglandin D2IBA 10/2020
1	Air Pollutants (Pollutants, Air)IBA 03/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 03/2020
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2020
1	Contrast MediaIBA 01/2020
1	Hormones (Hormone)IBA 06/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	MucinsIBA 01/2019
1	Bee Venoms (Bee Venom)IBA 01/2019
1	Peptides (Polypeptides)IBA 06/2016
1	olodaterolIBA 01/2016
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2015
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2015
1	OzoneIBA 01/2015
1	Nasal SpraysIBA 01/2015
1	azelastine (Optivar)FDA LinkGeneric 01/2015
1	polymeric IgAIBA 01/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2015
1	GlucocorticoidsIBA 01/2015
1	Oxygen (Dioxygen)IBA 12/2014
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 12/2014
1	SteroidsIBA 12/2014
1	Bacterial LysatesIBA 12/2014

Therapy/Procedure

16	Immunotherapy 07/2020 - 12/2009
14	Therapeutics 05/2022 - 05/2010
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2014
1	Premedication 01/2020
1	Activities of Daily Living (ADL) 01/2019
1	Inappropriate Prescribing 01/2018
1	Duration of Therapy 01/2018
1	Nebulizers and Vaporizers (Inhaler) 01/2016
1	Injections 12/2015